Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming 650111, China
zzy1370@163.com
Show less
History+
Received
Accepted
Published Online
2016-06-03
2016-09-01
2017-01-05
PDF
(1445KB)
Abstract
One of the primary purposes of the innovative development of ethnomedicines is to use their excellent safety and significant efficacy to serve a broader population. To achieve this purpose, modern scientific and technological means should be referenced, and relevant national laws and regulations as well as technical guides should be strictly followed to develop standards and to perform systemic research in producing ethnomedicines. Finally, ethnomedicines, which are applied to a limited extent in ethnic areas, can be transformed into safe, effective, and quality-controllable medical products to relieve the pain of more patients. The innovative development path of ethnomedicines includes the following three primary stages: resource study, standardized development research, and industrialization of the achievements and efforts for internationalization. The implementation of this path is always guaranteed by the research and development platform and the talent team. This article is based on the accumulation of long-term practice and is combined with the relevant disciplines, laws and regulations, and technical guidance from the research and development of ethnomedicines. The intention is to perform an in-depth analysis and explanation of the major research thinking, methods, contents, and technical paths involved in all stages of the innovative development path of ethnomedicines to provide useful references for the development of proper ethnomedicine use.
ZhuZ, WangT, FuD, GuiY, WangJ, CuiT. Innovative development path of ethnomedicines: an overview of ethnomedicines in China. Front Med2016; 10(2): 166–177
[2]
LiF, MaSR. Introduction to Chinese Ethnomedicine. 1st ed. Beijing: China Press of Traditional Chinese Medicine, 2009 (in Chinese)
[3]
CuiJ, TangL. Introduction to Traditional Medicine in Chinese Minorities. 1st ed. Beijing: Minzu University of China Press, 2007 (in Chinese)
[4]
WangZH, XiangXW. Thought on the protection, inheritance, and development of the traditional medicinal culture of minorities. J Yunnan Coll Tradit Chin Med (Yunnan Zhong Yi Xue Yuan Xue Bao) 2012; 35(2): 1–4 (in Chinese)
[5]
DuRF. Intellectual Property Right Protection of Chinese Traditional Medicine. 1st ed. Beijing: People’s Court Press, 2005 (in Chinese)
[6]
HuangCG. Status and development of folk medicine in the contemporary medicine of China. Capital Med (Shou Du Yi Yao) 1998; 5(7): 34 (in Chinese)
[7]
DuJ. Basic method of investigation on ethnomedicines. J Med Pharm Chin Minorities(Zhongguo Min Zu Yi Yao Za Zhi) 2008; 6(6): 47–48 (in Chinese)
[8]
YiLT. Several thoughts on the methods and means of rescue excavation of ethnomedicines. J Med Pharm Chin Minorities (Zhongguo Min Zu Yi Yao Za Zhi) 2012; 1(1): 76–77 (in Chinese)
[9]
PeiSJ. Discussion on the research of Chinese ethnomedicines and the development of new drugs (Part 1). J Yunnan Coll Tradit Chin Med (Yunnan Zhong Yi Xue Yuan Xue Bao) 2007; 30(3): 1–4 (in Chinese)
WangWQ. Chinese Medicine Resources. 1st ed. Beijing: China Press of Traditional Chinese Medicine, 2012 (in Chinese)
[16]
WangYM, LeiGL. Wildlife Identification and Investigation. 1st ed. Kunming: The Nationalities Publishing House of Yunnan, 2007 (in Chinese)
[17]
ChenHL, LuXD. Chinese Medicine Resources. 1st ed. Shenyang: Liaoning University Press, 1998 (in Chinese)
[18]
ZhaoST, GuoL, CaiL. Application of 3S technologies in medicinal plants resources investigation. J Minzu University China (Zhong Yang Min Zu Da Xue Xue Bao) 2009; 18(4): 18–25 (in Chinese)
[19]
XiaB, ChenZM, GuoZR. Ethnobotany and Medicinal Plants. 1st ed. Nanjing: Southeast University Press, 2006 (in Chinese)
[20]
Northwest Plateau Biology Institute, Chinese Academy of Sciences. The Annals of Tibetan Medicines. 1st ed. Xining: Qinghai People Publishing House, 1991 (in Chinese)
[21]
Institute of Drug Research, Tibet Autonomous Region Tibetan Hospital. State Administration of Traditional Chinese Medicine. Editorial Committee of Chinese Materia Medica. Chinese Materia Medica: Tibetan Medicine Volume. 1st ed. Shanghai: Shanghai Scientific and Technical Publishers, 2002 (in Chinese)
[22]
State Pharmacopoeia Commission of China. Pharmacopoeia of the People’s Republic of China. 1st ed. Beijing: China Medico Pharmaceutical Science and Technology Publishing House, 2015 (in Chinese)
[23]
ZhuYZ, ZhaoY, WeiQH. The Annals of National Medicines in Yunnan. 4th ed. Beijing: Science Press, 2012 (in Chinese)
[24]
XieZW, YuYC. Name of Chinese Herbal Medicine in China. 1st ed. Beijing: People’s Medical Publishing House, 1996 (in Chinese)
[25]
JiangB, DuanBZ. Bai Nationality Traditional Plant Medicine. 1st ed. Beijing: China Traditional China Medicine Publisher, 2014 (in Chinese)
[26]
ZhengHC, CaiSQ. Pharmaceutical Botany and Pharmacognosy. 4th ed. Beijing: People’s Medical Publishing House, 2003 (in Chinese)
[27]
CuiDF. Plant Taxonomy. 3rd ed. Beijing: China Agricultural Press, 2010 (in Chinese)
[28]
ZhengLY. Principles and Methods of Animal Classification. 1st ed. Beijing: Higher Education Press, 1987 (in Chinese)
[29]
GaoTA, MaJA, LiuRL. Illustrations and Application of Authenticity of Mineral Medicine. 1st ed. Taiyuan: Shanxi Science and Technology Press, 2014 (in Chinese)
[30]
LinRC. Mineral Drug Testing Technology and Quality Control. 1st ed. Beijing: Science Press, 2013 (in Chinese)
[31]
LiSR. Crystallography and Mineralogy. 1st ed. Beijing: Geological Publishing House, 2008 (in Chinese)
[32]
ZhangBL, FanXH, LiuY, ZhaiHB, ZhangJH, ChengYY. Secondary development strategy and core technology system of Chinese patent medicine. China J Chin Mater Med (Zhongguo Zhong Yao Za Zhi) 2013; 38(22): 3797–3800 (in Chinese)
[33]
ShangHC, LiuY, ZhangJH, WangH, XuHJ, ZhangBL, LiYP. Key points for clinical orientation in the secondary development of famous and superior Chinese patent drugs. Chin J Integr Tradit West Med (Zhongguo Zhong Xi Yi Jie He Za Zhi) 2008; 28(10):939–940 (in Chinese)
[34]
LiuY, LiQ, WangXF. Analysis of complexity of Chinese medicine industrial chain. China J Chin Mater Med (Zhongguo Zhong Yao Za Zhi) 2014; 39(16): 3187–3190 (in Chinese)
[35]
LiY, ZhongSH. Discussion on ethnic crude drug production from industry chain of ethnomedicines. J Chengdu Med (Chengdu Yi Xue Yuan Xue Bao) 2011; 6(1): 87–89 (in Chinese)
[36]
YangCR. The world of Yunnan Medicine and the Yunnan Medicine of world. J Yunnan Coll Tradit Chin Med (Yunnan Zhong Yi Xue Yuan Xue Bao) 2005; 28(4): 1–4 (in Chinese)
[37]
RanMX. Research and evaluation of Guizhou Miao ethnomedicines and modernization of Chinese medicine. J Chin Med Materls (Zhong Yao Cai) 2010; 33(2): 163–167 (in Chinese)
[38]
HuXF, WuXM. Present Situation and recommendation of development of China’s pharmaceutical distribution industry. Herald Med (Yi Yao Dao Bao) 2015; 34(1): 126–130 (in Chinese)
[39]
PanYJ, YangJ, HeL, ChenF, LiSJ, YanXQ, ZhangJ, QiuPY, LuGZ, YanFL. Analysis for Patent Protection of Chinese ethnomedicines. Chin J Exp Med Formul (Zhongguo Shi Yan Fang Ji Xue Za Zhi) 2011; 17(22): 261–264 (in Chinese)